S&P 500   3,271.03 (-3.53%)
DOW   26,519.95 (-3.43%)
QQQ   271.64 (-3.90%)
AAPL   111.20 (-4.63%)
MSFT   202.68 (-4.96%)
FB   267.67 (-5.51%)
GOOGL   1,510.80 (-5.51%)
AMZN   3,162.78 (-3.76%)
TSLA   406.02 (-4.39%)
NVDA   505.08 (-5.75%)
BABA   307.94 (-2.90%)
CGC   18.34 (-1.71%)
GE   7.42 (+4.51%)
MU   50.00 (-3.77%)
AMD   76.40 (-3.14%)
T   26.50 (-1.56%)
F   7.70 (-2.78%)
ACB   3.83 (-4.25%)
GILD   58.72 (-2.15%)
NFLX   486.24 (-0.55%)
NIO   27.51 (-3.27%)
BA   148.14 (-4.57%)
DIS   118.47 (-3.93%)
S&P 500   3,271.03 (-3.53%)
DOW   26,519.95 (-3.43%)
QQQ   271.64 (-3.90%)
AAPL   111.20 (-4.63%)
MSFT   202.68 (-4.96%)
FB   267.67 (-5.51%)
GOOGL   1,510.80 (-5.51%)
AMZN   3,162.78 (-3.76%)
TSLA   406.02 (-4.39%)
NVDA   505.08 (-5.75%)
BABA   307.94 (-2.90%)
CGC   18.34 (-1.71%)
GE   7.42 (+4.51%)
MU   50.00 (-3.77%)
AMD   76.40 (-3.14%)
T   26.50 (-1.56%)
F   7.70 (-2.78%)
ACB   3.83 (-4.25%)
GILD   58.72 (-2.15%)
NFLX   486.24 (-0.55%)
NIO   27.51 (-3.27%)
BA   148.14 (-4.57%)
DIS   118.47 (-3.93%)
S&P 500   3,271.03 (-3.53%)
DOW   26,519.95 (-3.43%)
QQQ   271.64 (-3.90%)
AAPL   111.20 (-4.63%)
MSFT   202.68 (-4.96%)
FB   267.67 (-5.51%)
GOOGL   1,510.80 (-5.51%)
AMZN   3,162.78 (-3.76%)
TSLA   406.02 (-4.39%)
NVDA   505.08 (-5.75%)
BABA   307.94 (-2.90%)
CGC   18.34 (-1.71%)
GE   7.42 (+4.51%)
MU   50.00 (-3.77%)
AMD   76.40 (-3.14%)
T   26.50 (-1.56%)
F   7.70 (-2.78%)
ACB   3.83 (-4.25%)
GILD   58.72 (-2.15%)
NFLX   486.24 (-0.55%)
NIO   27.51 (-3.27%)
BA   148.14 (-4.57%)
DIS   118.47 (-3.93%)
S&P 500   3,271.03 (-3.53%)
DOW   26,519.95 (-3.43%)
QQQ   271.64 (-3.90%)
AAPL   111.20 (-4.63%)
MSFT   202.68 (-4.96%)
FB   267.67 (-5.51%)
GOOGL   1,510.80 (-5.51%)
AMZN   3,162.78 (-3.76%)
TSLA   406.02 (-4.39%)
NVDA   505.08 (-5.75%)
BABA   307.94 (-2.90%)
CGC   18.34 (-1.71%)
GE   7.42 (+4.51%)
MU   50.00 (-3.77%)
AMD   76.40 (-3.14%)
T   26.50 (-1.56%)
F   7.70 (-2.78%)
ACB   3.83 (-4.25%)
GILD   58.72 (-2.15%)
NFLX   486.24 (-0.55%)
NIO   27.51 (-3.27%)
BA   148.14 (-4.57%)
DIS   118.47 (-3.93%)
Log in
NYSE:CNC

Centene Stock Forecast, Price & News

$61.16
-2.98 (-4.65 %)
(As of 10/28/2020 12:00 AM ET)
Add
Compare
Today's Range
$61.03
Now: $61.16
$63.31
50-Day Range
$54.30
MA: $61.18
$67.42
52-Week Range
$43.96
Now: $61.16
$74.70
Volume3.32 million shs
Average Volume4.57 million shs
Market Capitalization$35.44 billion
P/E Ratio21.46
Dividend YieldN/A
Beta0.59
Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. The company's Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which covers dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions, limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. Its Specialty Services segment provides pharmacy benefits management services; health, triage, wellness, and disease management services; and vision and dental, and management services, as well as care management software that automate the clinical, administrative, and technical components of care management programs. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Read More
Centene logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.5Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.07 out of 5 stars

Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
CUSIP15135B10
Phone314-725-4477
Employees56,600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$74.64 billion
Cash Flow$6.06 per share
Book Value$30.50 per share

Profitability

Net Income$1.32 billion

Miscellaneous

Market Cap$35.44 billion
Next Earnings Date2/2/2021 (Estimated)
OptionableOptionable
$61.16
-2.98 (-4.65 %)
(As of 10/28/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CNC News and Ratings via Email

Sign-up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Centene (NYSE:CNC) Frequently Asked Questions

How has Centene's stock been impacted by COVID-19?

Centene's stock was trading at $57.95 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CNC shares have increased by 5.5% and is now trading at $61.16.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Centene?

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Centene in the last year. There are currently 2 hold ratings, 16 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Centene
.

When is Centene's next earnings date?

Centene is scheduled to release its next quarterly earnings announcement on Tuesday, February 2nd 2021.
View our earnings forecast for Centene
.

How were Centene's earnings last quarter?

Centene Corp (NYSE:CNC) announced its quarterly earnings data on Tuesday, October, 27th. The company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.30. The firm earned $29.09 billion during the quarter, compared to analyst estimates of $28.30 billion. Centene had a return on equity of 14.07% and a net margin of 1.70%. The firm's revenue was up 53.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.96 EPS.
View Centene's earnings history
.

When did Centene's stock split? How did Centene's stock split work?

Centene's stock split on Wednesday, February 6th 2019. The 2-1 split was announced on Tuesday, February 5th 2019. The newly minted shares were distributed to shareholders after the closing bell on Tuesday, February 5th 2019. An investor that had 100 shares of Centene stock prior to the split would have 200 shares after the split.

What guidance has Centene issued on next quarter's earnings?

Centene issued an update on its FY20 earnings guidance on Tuesday, October, 27th. The company provided EPS guidance of $4.90-5.06 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.88. The company issued revenue guidance of $109.8-111.4 billion, compared to the consensus revenue estimate of $110.60 billion.

What price target have analysts set for CNC?

19 analysts have issued 12-month price targets for Centene's shares. Their forecasts range from $67.50 to $103.00. On average, they anticipate Centene's share price to reach $83.19 in the next year. This suggests a possible upside of 36.0% from the stock's current price.
View analysts' price targets for Centene
.

Are investors shorting Centene?

Centene saw a increase in short interest during the month of September. As of September 30th, there was short interest totaling 9,280,000 shares, an increase of 15.3% from the September 15th total of 8,050,000 shares. Based on an average daily trading volume, of 3,230,000 shares, the short-interest ratio is currently 2.9 days.
View Centene's Short Interest
.

Who are some of Centene's key competitors?

What other stocks do shareholders of Centene own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Centene investors own include NVIDIA (NVDA), Alibaba Group (BABA), UnitedHealth Group (UNH), Micron Technology (MU), CVS Health (CVS), Intel (INTC), Johnson & Johnson (JNJ), Visa (V), AbbVie (ABBV) and Cisco Systems (CSCO).

Who are Centene's key executives?

Centene's management team includes the following people:
  • Mr. Michael Frederic Neidorff, Chairman, Pres & CEO (Age 76)
  • Mr. Jeffrey Alan Schwaneke C.P.A., CPA, Exec. VP, CFO & Treasurer (Age 43)
  • Ms. Brandy Lynn Burkhalter, Exec. VP of Operations (Age 46)
  • Mr. Mark J. Brooks, Exec. VP & Chief Information Officer (Age 49)
  • Mr. Jesse N. Hunter, Exec. VP & Chief Strategy Officer (Age 43)

What is Centene's stock symbol?

Centene trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNC."

Who are Centene's major shareholders?

Centene's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vantage Investment Partners LLC (0.50%), Assenagon Asset Management S.A. (0.22%), Scharf Investments LLC (0.16%), Psagot Investment House Ltd. (0.10%), Cortland Associates Inc. MO (0.09%) and Cambiar Investors LLC (0.08%). Company insiders that own Centene stock include Brandy Burkhalter, Christopher D Bowers, Jeffrey A Schwaneke, Jesse N Hunter, Jessica L Blume, John R Roberts, Keith H Williamson, Kenneth A Burdick, Mark J Brooks, Michael F Neidorff, Orlando Ayala, Richard A Gephardt, Robert K Ditmore and Tommy G Thompson.
View institutional ownership trends for Centene
.

Which major investors are selling Centene stock?

CNC stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Envestnet Asset Management Inc., DNB Asset Management AS, Scout Investments Inc., Alberta Investment Management Corp, Crossmark Global Holdings Inc., Standard Life Aberdeen plc, and State of New Jersey Common Pension Fund D. Company insiders that have sold Centene company stock in the last year include Brandy Burkhalter, Jeffrey A Schwaneke, Jesse N Hunter, John R Roberts, Keith H Williamson, Kenneth A Burdick, Michael F Neidorff, Orlando Ayala, Richard A Gephardt, Robert K Ditmore, and Tommy G Thompson.
View insider buying and selling activity for Centene
.

Which major investors are buying Centene stock?

CNC stock was bought by a variety of institutional investors in the last quarter, including Scharf Investments LLC, Vantage Investment Partners LLC, Psagot Investment House Ltd., Cambiar Investors LLC, Rhenman & Partners Asset Management AB, Moody National Bank Trust Division, State of Alaska Department of Revenue, and Pennsylvania Capital Management Inc. ADV.
View insider buying and selling activity for Centene
.

How do I buy shares of Centene?

Shares of CNC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Centene's stock price today?

One share of CNC stock can currently be purchased for approximately $61.16.

How big of a company is Centene?

Centene has a market capitalization of $35.44 billion and generates $74.64 billion in revenue each year. The company earns $1.32 billion in net income (profit) each year or $4.42 on an earnings per share basis. Centene employs 56,600 workers across the globe.

What is Centene's official website?

The official website for Centene is www.centene.com.

How can I contact Centene?

Centene's mailing address is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. The company can be reached via phone at 314-725-4477 or via email at [email protected]

This page was last updated on 10/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.